Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'biotin 16 aminoallyluridine 17 triphosphate'

Search results for: 'biotin 16 aminoallyluridine 17 triphosphate'

Items 211-220 of 220

Page
per page
  1. Wortmannin
    A8544 Wortmannin
     5 Citation
    Summary: PI3K inhibitor,selective and irreversible
      ≥21.42 mg/mL
  2. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      insoluble in EtOH; ≥23.8 mg/mL
  3. Palbociclib (PD0332991) Isethionate
    A8335 Palbociclib (PD0332991) Isethionate
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥28.7 mg/mL
  4. ZSTK474
    A8248 ZSTK474
    Summary: Potent PI3K inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
  5. Epothilone B (EPO906, Patupilone)
    A1630 Epothilone B (EPO906, Patupilone)
    Target: Microtubules/Tubulins
    Summary: Microtubule stabilizing macrolide
      ≥25.4 mg/mL
  6. PD 0332991 (Palbociclib) HCl
    A8316 PD 0332991 (Palbociclib) HCl
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥14.48 mg/mL
  7. 2'-O-Methyl-2-Amino-ATP
    B7992 2'-O-Methyl-2-Amino-ATP
    Summary: Modified nucleoside triphosphate with methylation at the 2'-hydroxyl group and an amino substitution at the 2-position of the adenine ring, used for RNA stability studies.
  8. AT7867
    A5653 AT7867
    Target: Akt|PKA|p70 rsk
    Summary: Akt1/2/3 and p70S6K/PKA inhibitor
      ≥16.9 mg/mL
  9. GDC-0980 (RG7422)
    B2184 GDC-0980 (RG7422)
    Summary: Class I PI3K inhibitor for PI3Kα/β/δ/γ
      ≥21.35 mg/mL
  10. PKI-402
    A8505 PKI-402
    Summary: PI3K inhibitor,selective, reversible and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥14.28 mg/mL

Items 211-220 of 220

Page
per page